Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,135
in 3 filings

Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Abate Kristin −$2K Chief Accounting Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-01 Mitchener Stephen SVP, Chief Business Officer Sale −6,357 $3.03 $19K 128,313
2023-02-28 Mitchener Stephen SVP, Chief Business Officer Grant or award +60,000 134,670
2022-08-31 Mitchener Stephen SVP, Chief Business Officer Grant or award +20,000 70,546
2022-08-31 Mitchener Stephen SVP, Chief Business Officer Grant or award · Stock Option (right to buy) +30,000 30,000
2022-02-28 Mitchener Stephen SVP, Chief Business Officer Grant or award +47,250 50,546
2022-02-28 Mitchener Stephen SVP, Chief Business Officer Grant or award · Stock Option (right to buy) +59,400 59,400

Page 1 of 1 · 6 trades